US Patent Litigations are now available. Check here

Explore Engmab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 17, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3227333Aug 16, 2023Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases6